Abstract:Objective To investigate whether valproic acid(VPA) can affect autonomic activity and cerebral morphology and structure in the APP/PS1 double transgenic Alzheimer's disease(AD) mouse model,so as to explore the neuroprotective effect of VPA on AD.Methods Three-month old APP/PS1 double transgenic AD model mice and its wild-type littermates were randomly divided into two groups(VPA-treated group and saline-treated group),VPA [30 mg/(kg·d)] and the same amount of normal saline were peritoneally injected into mice for 4 weeks.Open field test was used to examine autonomous behaviors of AD model and wildtype mice.Nissl staining and transmission electron microscopy(TEM) were applied to observe the morphological structures in the brains of AD model mice.Results Open field test revealed that the autonomic activities of AD mice showed an obvious decrease when compared to wild-type mice(P<0.05),the autonomic activities of VPA-treated mice were decreased significantly compared with the saline-treated controls(P<0.05),while the autonomic activities of both VPA-treated and saline-treated wild-type mice showed no difference.Nissl staining showed that neuronal cells in the brain of AD model mice were greatly decreased compared with wild-type mice.Furthermore,neuronal cells in the brain of saline-treated AD model mice were severely reduced in number(85.2±13.3),and a large number of neurons became swollen and round,the nuclei were slightly stained,and the cytoplasm was pale in which Nissl bodies were reduced significantly.Administration of VPA notably suppressed the enhanced neuronal swelling and rescued the neuronal loss(116.9±16.2,P<0.05).VPA did not exert effect on the morphology and number of neuronal cells in the brain of both saline-treated and VPA-treated wildtype mice(142.2±24.4 vs 136.7±23.1,P>0.05).TEM revealed that the cytoplama,nucleus,part of mitochondria and neuropil in AD mice became obviously swollen,which were partially rescued by VPA.Meanwhile,the structure of synapse became clearer in VPA-treated mice.Conclusion VPA reduces the autonomous behavior and relieves manic symptoms in AD model mice.VPA may not only change the morphology of neuronal cells,but also rescue the neuronal loss in the brains of AD model mice.

Gender Difference in Valproic Acid-Induced Neuroprotective Effects on APP/PS1 Double Transgenic Mice Modeling Alzheimer's Disease

Effect of valproic acid on autonomous behaviors and cerebral morphology and structure in APP/PS1 double transgenic mice

The effect of valproic acid on senile plaques and neuron in the brain of APP/PS1 double transgenic AD model mouse

Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer’s Disease

Valproic Acid Inhibits Aβ Production, Neuritic Plaque Formation, and Behavioral Deficits in Alzheimer's Disease Mouse Models

Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase‐3β Signaling Pathway in an Alzheimer's Disease Model

Valproic acid reduces neuritic plaque formation and improves learning deficits in APPSwe/PS1A246E transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin

Valproic Acid Stimulates Hippocampal Neurogenesis Via Activating the Wnt/β-Catenin Signaling Pathway in the APP/PS1/Nestin-GFP Triple Transgenic Mouse Model of Alzheimer's Disease.

Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.

Histone Deacetylase Inhibitors VPA and WT161 Ameliorate the Pathological Features and Cognitive Impairments of the APP/PS1 Alzheimer’s Disease Mouse Model by Regulating the Expression of APP Secretases

Sex Differences in Hippocampal Β-Amyloid Accumulation in the Triple-Transgenic Mouse Model of Alzheimer’s Disease and the Potential Role of Local Estrogens

Sexual dimorphism in behavior, neuropathology, and biomarkers in a tau P301S mouse model of Alzheimer’s disease

Genetic Targeting Aromatase in Male Amyloid Precursor Protein Transgenic Mice Down-Regulates Β-Secretase (BACE1) and Prevents Alzheimer-Like Pathology and Cognitive Impairment

Gender Differences in the Bile Acid Profiles of APP/PS1 Transgenic AD Mice

Sex differences between APPswePS1dE9 mice in A-beta accumulation and pancreatic islet function during the development of Alzheimer’s disease

P1-101: Increasing Endogenous Testosterone Level Would Benefit Cognition and Prevent Amyloid Deposition in Transgenic Animal Brain

Gender Differences of Peripheral Plasma and Liver Metabolic Profiling in App/Ps1 Transgenic Ad Mice

AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease

Gender Differences of NLRP1 Inflammasome in Mouse Model of Alzheimer's Disease

Prostaglandin A1 Inhibits the Cognitive Decline of APP/PS1 Transgenic Mice via PPARγ/ABCA1-dependent Cholesterol Efflux Mechanisms

Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer's disease mouse model by regulating the expression of APP secretases